Search Results for:
-
Auxilium's Enzyme For Scar Tissue Effective In Phase III
It will be better for the health care system because the surgical procedure's cost is pretty significant, while at the same time, we ought to get a pretty good return for our shareholders by pricing this as a premium productBy Aaron Lorenzo | BioWorld Today | Thursday, June 22, 2006 -
Launch Of Europe's First Biogeneric Drug Imminent
Further launches in the European Union's 25 member states will follow reimbursement negotiations with the states' respective national health care systemsBy Cormac Sheridan | BioWorld Today | Wednesday, April 19, 2006 -
Launch Of Europe's First Biogeneric Drug Imminent
Further launches in the European Union's 25 member states will follow reimbursement negotiations with the states' respective national health care systemsBy Cormac Sheridan | BioWorld International | Wednesday, April 19, 2006 -
Other News To Note
The HAND initiative complements existing Genzyme programs that provide free medicines and help to build sustainable health care systems in developing countriesBioWorld Today | Wednesday, April 12, 2006 -
Diagnostics Seen As Hope For Future Of Health Care
While diseases such as HIV and malaria are a significant weight, the true cost challenges to health care systems come from chronic diseaseBy Nuala Moran | BioWorld Today | Thursday, March 30, 2006 -
Diagnostics Seen As Hope For Future Of Health Care
While diseases such as HIV and malaria are a significant weight, the true cost challenges to health care systems come from chronic diseaseBy Nuala Moran | BioWorld International | Wednesday, March 29, 2006 -
Bush Names As Permanent FDA Head von Eschenbach
The 64-year-old von Eschenbach, generally viewed as industry friendly, said increased attention in those areas from the public and private sectors would lead to a health care system that’s more personalized, predictive and pre-emptiveBy Aaron Lorenzo | BioWorld Today | Friday, March 17, 2006 -
After Recommendation, First Biosimilar Approval Imminent
Andreas Rummelt, CEO of Sandoz, said, "Omnitrope will contribute to cost savings in health care systems, and we are confident that the European Commission will now grant marketing authorizationBy Nuala Moran | BioWorld International | Wednesday, February 1, 2006 -
Bird Flu's Economic Toll Could Prove Long Lasting
Gingrich's group, which advocates improving health care by updating medical practices with 21st century technology, noted that all pandemic preparations would lay the groundwork for a far more advanced health care system - "a dual-use investment," he said, even if bird flu fears never become realityBy Aaron Lorenzo | BioWorld Today | Monday, December 19, 2005 -
2004 Venture Capital And Other Financings Of Private Biotechnology Firms
Company Location Date Amt. (M) Details JANUARY Athenix Corp. Research Triangle Park, N.C. 1/20/04 $12.50 Investors in the Series B financing were led by Intersouth Partners, Polaris Venture Partners and Boston Millennia Partners; participating were Hunt Ventures and Eastman Ventures Alimentary Health Ltd. Cork, Ireland 1/28/04 €1.3 (US$1.62) Alimentary raised €1.3M in a funding round led by Seroba Bioventures Ltd. Auxeris Therapeutics Inc. St. Louis 1/9/04 $4.10 AuxerisState of the Industry Report | Tuesday, May 10, 2005 -
Cash Squeeze Could Hamper Finnish Personalized Medicine
Its homogenous population and its state-run health care system, which has, over several decades, built up a rich store of epidemiological information, make it fertile ground for conducting population genetics studies...With access to greater predictability obtained through genomic information, health care systems will shift from caring for the needs of 5 percent of the population who are sick to maintaining the health of the majority of the population who are healthyBy Cormac Sheridan | BioWorld International | Wednesday, April 27, 2005 -
Genzyme Advances Diarrhea Product Into Pivotal Testing
It would not only serve as a treatment for the infection but also reduce the number of recurrences, resulting in improved quality of life and savings to the health care system, Genzyme saidBy Aaron Lorenzo | BioWorld Today | Tuesday, April 5, 2005 -
Leavitt To Head HHS After Receiving Senate Support
That initiative dates all the way back to the Clinton days to get savings in the health care system by bringing new communication technologies forward," Nawrocki saidBy Aaron Lorenzo | BioWorld Today | Monday, January 31, 2005 -
Venture Capital And Corporate Investments In Biotechnology Companies: November 2004
Dallas 11/1/04 $4 Baylor Health Care System formed the company and provided $4M in seed financing Procognia LtdBioWorld Insight | Monday, December 6, 2004 -
Lowering Cholesterol Through Methods Alternative To Statins
the Veterans Affairs Health Care System in Palo Alto, CalifBy Anette Breindl | BioWorld Today | Tuesday, November 16, 2004 -
What Four More Years Of Bush Might Mean To Biotech Sector
Speakers from the financial firm's newly formed Health Research Institute gave perspectives on Bush's second-term health care agenda and implications of policies and proposals aimed at the nation's health care systemBy Aaron Lorenzo | BioWorld Today | Thursday, November 11, 2004 -
Other News To Note
Aegera Therapeutics Inc., of Montreal, said findings detailing the origin and function of Skin-derived Precursors (SKPs), a source of multipotent adult stem cells, were published in Nature Cell Biology. The endogenous SKPs are established in skin during embryogenesis and persist into adulthood. SKPs are maintained in a precursor state within a niche, such as in the root of hair and whisker follicles. Agilent Technologies Inc. , of Palo Alto, Calif., completed its acquisition of SiliconBioWorld Today | Tuesday, November 2, 2004 -
Other News To Note
Acacia Research Corp., of Newport, Calif., said its CombiMatrix group entered an agreement with Intel Corp., of Santa Clara, Calif., to work together on the feasibility of various projects using CombiMatrix's core technology. It is developing a platform technology to produce customizable active biochips, which are semiconductor-based tools for use in identifying and determining the roles of genes, gene mutations and proteins. Terms and conditions were not disclosed. Adolor Corp. , of ExtonBioWorld Today | Thursday, September 9, 2004 -
PPARs Show Diabetes Promise; Regulator Caution Slows Work
Hirth called diabetes "a big issue for our health care systemBy Randall Osborne | BioWorld Insight | Monday, July 19, 2004 -
Report: 25 Recommendations For EU Strategies On Genetic Testing
Erik Tambuyzer, chairman of the health care board at EuropaBio, the European association of bioindustries, said genetic testing "will be a very important aspect of our future health care systemsBy Peter O'Donnell | BioWorld International | Wednesday, May 12, 2004
Category
Current Filters
- xcare system
Related Keywords
Categories
- x BioWorld Today (182)
- x BioWorld International (40)
- x Bio Perspectives (38)
- x BioWorld Insight (16)
- x BioWorld Genomics Review (3)
- x State of the Industry Report (2)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.